Body proportions in patients with Turner syndrome on growth hormone treatment
Turkish Journal of Medical Sciences · 01.01.2023 · 53 (2) · 518-525
DOI: 10.55730/1300-0144.5612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 01.01.2023. Verfasst von Aslı Derya Kardelen Al und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey ; Department of Pediatric Endocrinology, C…. Hauptthemen laut MEDLINE: Turner Syndrome, Human Growth Hormone. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In this cross-sectional study, we aimed to evaluate auxological measurements and detailed body proportions of recombinant human growth hormone (GH)-treated patients with Turner syndrome (TS) and compare them with a group of healthy females. Materials and methods: We evaluated 42 patients with TS who received GH treatment and 20 healthy controls. Anthropometric measurements were taken and target height, body mass index (BMI), arm span-height difference, extremity-to-trunk ratio, and Manouvrier's skelic index were calculated.
Results
The median (min-max) age of the patients at the time of evaluation was 13.6 (4.3-20.7) years, and the control group was 12.9 (3.8-23.7) years. Height, sitting height, and arm span of TS patients were significantly lower than those of the control group. Sitting height/height ratio (SHR) was in normal ranges in both groups and BMI was significantly higher in TS patients when compared to the control group. According to Manouvrier's skelic index, TS patients had shorter legs than the control group (p = 0.001). The extremity-trunk ratio was significantly decreased in TS patients compared to healthy controls (p < 0.001). There was no significant difference between the karyotype groups in terms of these indexes.
Conclusion
TS patients had short stature, increased BMI and waist circumference, normal head circumference, and decreased extremity-trunk ratio. Sitting height and leg length were short; however, the SHR standard deviation score (SDS) was in the normal range. Despite being treated with GH, TS patients had disproportionate short stature. The disproportion in TS patients was similar to short-stature homeobox-containing gene (SHOX) deficiency, which is considered to be SHOX haploinsufficiency in the etiopathogenesis of short stature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey ; Department of Pediatric Endocrinology, Child Health Institute, Istanbul University, İstanbul, Turkey.
- Department of Pediatric Endocrinology, Child Health Institute, Istanbul University, İstanbul, Turkey.
- Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Zitieren
APA
Al, A. D. K., Şükür, N. M., Özturan, E. K., Öztürk, A. P., Poyrazoğlu, Ş., Baş, F., & Darendeliler, F. F. (2023). Body proportions in patients with Turner syndrome on growth hormone treatment. Turkish Journal of Medical Sciences, 53(2), 518-525. https://doi.org/10.55730/1300-0144.5612
Vancouver
Al ADK, Şükür NM, Özturan EK, Öztürk AP, Poyrazoğlu Ş, Baş F, et al. Body proportions in patients with Turner syndrome on growth hormone treatment. Turkish Journal of Medical Sciences. 2023;53(2):518-525. doi:10.55730/1300-0144.5612
BibTeX
@article{Al2023,
author = {Al, Aslı Derya Kardelen and Şükür, Nur Mine and Özturan, Esin Karakılıç and Öztürk, Ayşe Pınar and Poyrazoğlu, Şükran and Baş, Firdevs and Darendeliler, Fatma Feyza},
title = {Body proportions in patients with Turner syndrome on growth hormone treatment},
journal = {Turkish Journal of Medical Sciences},
year = {2023},
volume = {53},
number = {2},
pages = {518--525},
doi = {10.55730/1300-0144.5612}
}
EUVIMED